Team:Hong Kong HKUST/results
From 2013.igem.org
(Difference between revisions)
Line 206: | Line 206: | ||
</div> | </div> | ||
<br><br><br> | <br><br><br> | ||
- | <div id="slide"><center><h3 class="title">Result</h3></center | + | <div id="slide"><center><br><h3 class="title">Result</h3></center><br> |
<p id="yo">Our project was first proposed in mid-March and after a series of improvement and elaboration, we started our wet lab work from mid-June to late-September. After 3 months of memorable diligent work, we are proud to claim that we have achieved the results below: | <p id="yo">Our project was first proposed in mid-March and after a series of improvement and elaboration, we started our wet lab work from mid-June to late-September. After 3 months of memorable diligent work, we are proud to claim that we have achieved the results below: | ||
<ul> | <ul> |
Revision as of 12:07, 26 September 2013
![](https://static.igem.org/mediawiki/igem.org/c/c7/BANNER1_%281%29.png)
Result
Our project was first proposed in mid-March and after a series of improvement and elaboration, we started our wet lab work from mid-June to late-September. After 3 months of memorable diligent work, we are proud to claim that we have achieved the results below:
- Successfully construct the two parts for mitochondria leader sequence, MLS with RFC 10 and RFC 25, (BBa_K1119000, BBa_K1119001).
- Successfully construct the part of aceA and aceB for in glyoxylate shunt (BBa_K1119002, BBa_K1119003).
- Successfully construct the part of a constitutive regulatory promoter, Human Elongation Factor 1-alpha promoter (BBa_K1119004).
- Successfully construct the part for a constitutive CMV promoter (BBa_K1119006).
- Successfully characterized the regulatory promoter pCMV in HEK293FT cells (BBa_K1119008).
- Successfully characterized the mitochondria leader sequence MLS in HEK293FT cells (BBa_K1119009).
- Successfully tested the HepG2 cell viability in different sodium palmitate concentrations.